AI Bio Atlas LogoaibioatlasSEARCH • COMPARE • CHOOSE
Home›AI Drug Discovery›Pharma.AI
drug-discoveryDrug Discovery & Chemistry
AI Drug Discovery · End-to-End AI Drug Discovery Platform

Pharma.AI

By Insilico Medicine →

Integrated generative AI platform from target discovery to clinical candidate design

Pharma.AI is Insilico Medicine’s proprietary generative AI platform that integrates target discovery (PandaOmics), de novo small-molecule generation (Chemistry42), and clinical trial outcome prediction (inClinico).

PandaOmics for multi-omics target identification and biological aging biomarker analysisChemistry42 generative chemistry platform with 42 distinct generative algorithmsDemonstrated progression of novel targets and molecules into Phase II clinical trials (e.g. ISM001-055 for IPF)High-throughput synthetic accessibility and automated ADMET filtering
Compare

ℹ️ No direct buying or access link is currently recorded. This product remains available for research and comparison.

Report incorrect information or a broken link →

Overview

Pharma.AI is Insilico Medicine’s proprietary generative AI platform that integrates target discovery (PandaOmics), de novo small-molecule generation (Chemistry42), and clinical trial outcome prediction (inClinico).

Information checked against an official source; not a hands-on test. Source · Last reviewed: 20/09/2026, 11:10:15

Key Features

  • PandaOmics for multi-omics target identification and biological aging biomarker analysis
  • Chemistry42 generative chemistry platform with 42 distinct generative algorithms
  • Demonstrated progression of novel targets and molecules into Phase II clinical trials (e.g. ISM001-055 for IPF)
  • High-throughput synthetic accessibility and automated ADMET filtering
Interactive 3D Structure

Pharma.AI Predicted Complex

Streams real 3D atomic coordinates from RCSB Protein Data Bank
⇄ Drag to rotate · Scroll to zoom
pLDDT / B-Factor:
>90 Very high 70-90 Confident 50-70 Low <50 Very low

Academic Context & Research Evidence

Biological & Workflow Fit

Biological Application
Fibrosis, oncology, immunology, and age-related disease drug discovery
Research Workflow
Disease multi-omics data -> novel target selection -> generative chemistry -> candidate synthesis
Compute & Hardware
Cloud SaaS with enterprise security compliance
Licensing & Academic Use
Proprietary commercial software
Documented Evidence
View validation publication / source ↗

Cite this Tool

Use this citation format when referencing Pharma.AI in scientific publications and benchmark papers.

@software{insilico_pharma_ai_2026,
  title = {{Pharma.AI}},
  author = {{Insilico Medicine}},
  year = {2026},
  url = {https://insilico.com/platform},
  note = {Indexed on aibioatlas - AI for Biology and Drug Discovery}
}

Peer-Reviewed Literature & Preprints

Live scientific citations streamed from Europe PMC and PubMed for Pharma.AI.

⏳ Fetching real-time literature from Europe PMC & PubMed...

Technical / Product Information

Missing values mean the catalog has no recorded information. They do not mean a feature is absent.

Entry typeCommercial Platform
Access modeCommercial Subscription & Co-Development
AI roleEnd-to-End Generative Chemistry
Input dataNot recorded
Output dataNot recorded
Licence conditionsProprietary commercial software
Commercial eligibilityCommercial enterprise licensing and drug discovery partnerships
Compute requirementsCloud SaaS with enterprise security compliance
ValidationNot recorded
TypeEnd-to-end generative AI drug platform
Intended useNot recorded
CompatibilityNot recorded
ManufacturerInsilico Medicine
Biological applicationFibrosis, oncology, immunology, and age-related disease drug discovery
Research workflowDisease multi-omics data -> novel target selection -> generative chemistry -> candidate synthesis
Evidence levelClinical-stage pipeline with published experimental and clinical validation (Nature Biotech 2024)
Integration evidencehttps://insilico.com/platform
Laboratory handoffCompounds synthesized in automated robotic labs for biochemical IC50 testing
AvailabilityGlobally available for biopharma partners
Price / accessEnterprise partnership — contact vendor

Research fit & compatibility

No software–hardware integration has been verified for this entry yet. Explore documented research workflows.

Gallery & resources

No licensed product photograph recorded for Pharma.AI yet. Visit the official resource below for manufacturer imagery.

BEFORE YOU CHOOSE

Evaluate AI Drug Discovery

  • Which input, output and scientific task does the selected version support?
  • Is this a model, supporting tool, commercial platform or research prototype?
  • Verify the code, weights, data licence and independent validation before selecting a workflow.
Selection guide →Find alternatives →

Alternatives

Similar entries from the same category.

drug-discoveryAI Drug Discovery
Retrosynthesis

ASKCOS

Research software / framework · Public code / project terms

Computer-aided organic synthesis planning

MIT / MLPDS Consortium

See project terms; compute costs may apply
Explore →＋ Compare

FAQ

Where is this product available?

Globally available for biopharma partners

How is pricing handled?

Prices reflect the source at its last check. Confirm current pricing and regional availability on the official site.

Share this entry with your lab or research teamSpread reproducible science across your network
𝕏 Postin LinkedIn

Peer Reviews & Community Ratings

Feedback from researchers and computational biologists evaluating Pharma.AI.

5.0
★★★★★Based on 0 researcher evaluations
Biological Accuracy
4.8/5
Ease of Installation
4.3/5
Documentation & Code
4.6/5